 |
|
|
|
 |
- Memorial Sloan-Kettering's First Freestanding Outpatient Facility Opens in New Jersey
December 2006 - The newest addition to the Memorial Sloan-Kettering regional network is a state-of-the-art, 85,000-square-foot outpatient cancer treatment facility situated on 26 wooded acres in Basking Ridge, New Jersey. - An Interview with Alan Hall
December 2006 -Alan Hall, Chair of the Sloan-Kettering Institute's Cell Biology Program, discusses his far-ranging professional journey and explains his research objectives and program goals at Sloan-Kettering Institute. - Newly Approved Cancer Drug Based on 30 Years of Research
December 2006 - A drug developed at Memorial Sloan-Kettering Cancer Center and Columbia University has won approval from the US FDA. Vorinostat (Zolinza™) -- also known by its chemical name suberoylanilide hydroxamic acid (SAHA) -- was approved in October for the treatment of cutaneous T cell lymphoma (CTCL), a form of non-Hodgkin's lymphoma. - T Cell Precursors Improve Immune Response After Bone Marrow Transplantation
December 2006 - A study led by immunologist and Adult Bone Marrow Transplant Service Chief Marcel R. van den Brink has demonstrated a novel strategy for boosting numbers of infection-fighting T cells in mice after allogeneic bone marrow transplantation. - When Biology Meets Structure
December 2006 - A collaboration driven by Jayakrishnan Nandakumar, a fifth-year graduate student in the Tri-Institutional Training Program in Chemical Biology, and guided by Sloan-Kettering Institute researchers Christopher Lima and Stewart Shuman, has led to the exquisite visualization of RNA ligase 2 (Rnl2). - Memorial Sloan-Kettering Transplant Survivors Celebrate Life at 11th Annual Party
December 2006 - More than 400 guests gathered in the Rockefeller Research Laboratories on October 26 for the 11th annual Stem Cell Transplant Survivors Celebration. - Joan Massagué Elected to Institute of Medicine
December 2006 - Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan-Kettering Institute, has been elected a member of the Institute of Medicine (IOM).
|
|
|
|
|
